All of the investigational agents that are currently under development by Benitec employ tissue -specific delivery vectors (e.g. AAV9) whereas BB-401 has no delivery vector and was deliveredintratumorally as a “naked” plasmidStick it in and hope it works?
- Forums
- ASX - By Stock
- BLT
- Ann: Benitec Provides Update on BB-401 Cancer Treatment Program
Ann: Benitec Provides Update on BB-401 Cancer Treatment Program, page-4
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online